Skip to main content
Premium Trial:

Request an Annual Quote

Dharmacon s siGenome and Cisbio International s HTRF Assays

Premium

Dharmacon has recently introduced additional siRNA reagents targeting the mouse and rat genomes to the company’s existing siGenome human siRNA collection.

According to the company, the siGenome collection consists of more than 300,000 highly functional siRNA reagents including Smartpool siRNA reagents, Smartselection-designed target gene siRNA sets, and individual Smartselection-designed siRNA duplexes targeting all unique genes in the NCBI RefSeq database. The mouse and rat siRNA additions to siGenome are available online at http://www.dharmacon.com.


Cisbio International said it has added kinase and ubiquitin toolboxes to its portfolio of HTRF (homogenous time-resolved fluorescence) assays for high-throughput screening. The new toolboxes will cover a broad range of kinase and polyubiquitination-related targets, Cisbio said.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.